Weight-Loss Drug Might Benefit Those With Type 2
The weight-loss drug lorcaserin (Belviq) might help reduce blood glucose levels in people with type 2 diabetes or prediabetes. In a study, 12,000 people were randomly assigned to take lorcaserin or a placebo for about three years, and all had access to a weight-management program. Just over half of the group had type 2 diabetes, and a third had prediabetes. Not surprisingly, those taking lorcaserin lost about 5 to 7 pounds more than the placebo group did. But that’s not all: A1C levels—a measure of average glucose levels over six to eight weeks—were lower overall with lorcaserin, and those with prediabetes who took lorcaserin were less likely to develop type 2 diabetes. This was a short-term trial, and there are still some long-term safety concerns with the drug. Lorcaserin isn’t right for everyone, so discuss the pros and cons with your doctor.
Source: The New England Journal of Medicine, published online Oct. 4, 2018